SubsidieMeestersSaving patients from severe heart failure
The ICOMS FlowMaker® is a novel intracardiac assist device designed to improve the quality of life for severe heart failure patients, aiming for EU market entry by 2026 through clinical trials.
Projectdetails
Introduction
The ICOMS FlowMaker® is the first intracardiac assist device that overcomes all shortcomings of current and under development devices and restores patient's quality of life.
Design and Functionality
Its design perfectly fits all the needs of patients suffering from severe heart failure. Implanted inside the left ventricle and synchronized with the natural heartbeat, it assists the heart to push blood in a physiological way.
Advantages
- The very low electrical consumption allows for wireless functioning.
- With no driveline crossing the skin, the risk of infection is suppressed.
- Without bypass to aorta and thanks to its pulsatile mode, the risk of bleeding is very low.
Market Need
The ICOMS FlowMaker® addresses the market of severe heart failure, where 95% of patients are left without any solution.
Project Aim
The aim of the project is to conduct the clinical trials to enter the EU market in 2026, then the US market, allowing to finally achieve EU sovereignty in severe heart failure treatment.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 9.903.923 |
Tijdlijn
| Startdatum | 1-10-2022 |
| Einddatum | 31-3-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- FINEHEARTpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Autonomous robotics and digital TWIN to improve water network performancesThe project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model. | EIC Accelerator | € 2.478.210 | 2024 | Details |
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming systemToopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability. | EIC Accelerator | € 2.396.457 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Autonomous robotics and digital TWIN to improve water network performances
The project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model.
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system
Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
SPARK - Subcutaneous Pump and Advanced Remote KitRT Cardiac Systems ontwikkelt een innovatief percutaan mechanisch circulatieondersteuningsapparaat en een subcutane sensor om patiënten met gevorderd hartfalen beter te ondersteunen tijdens noodsituaties en ingrepen. | MIT R&D Samenwerking | € 199.138 | 2023 | Details |
Mechanical design concept for Cardiac Recovery Assist DeviceCardiacBooster ontwikkelt een veilig mechanisch device voor hartondersteuning bij acuut hartfalen, met focus op haalbaarheid en validatie via testen en samenwerking met derden. | MIT Haalbaarheid | € 20.000 | 2020 | Details |
SPARK - Subcutaneous Pump and Advanced Remote KitHet project ontwikkelt een innovatief hartondersteuningssysteem met een subcutane sensor voor betere behandeling van gevorderd hartfalen. | MIT R&D Samenwerking | € 199.138 | 2023 | Details |
SPARK - Subcutaneous Pump and Advanced Remote Kit
RT Cardiac Systems ontwikkelt een innovatief percutaan mechanisch circulatieondersteuningsapparaat en een subcutane sensor om patiënten met gevorderd hartfalen beter te ondersteunen tijdens noodsituaties en ingrepen.
Mechanical design concept for Cardiac Recovery Assist Device
CardiacBooster ontwikkelt een veilig mechanisch device voor hartondersteuning bij acuut hartfalen, met focus op haalbaarheid en validatie via testen en samenwerking met derden.
SPARK - Subcutaneous Pump and Advanced Remote Kit
Het project ontwikkelt een innovatief hartondersteuningssysteem met een subcutane sensor voor betere behandeling van gevorderd hartfalen.